My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Conquer Addiction PLLC DBA Conquer 7/26/2024
>
Contracts
>
6 Years Then Destroy
>
2024
>
Conquer Addiction PLLC DBA Conquer 7/26/2024
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/7/2024 10:14:15 AM
Creation date
8/7/2024 10:13:43 AM
Metadata
Fields
Template:
Contracts
Contractor's Name
Conquer Addiction PLLC DBA Conquer
Approval Date
7/26/2024
Council Approval Date
5/1/2024
End Date
12/31/2024
Department
Community Development
Department Project Manager
Kembra Landry
Subject / Project Title
EMOTE Program
Tracking Number
0004461
Total Compensation
$309,360.00
Contract Type
Agreement
Contract Subtype
Grant Agreement (City as Grantor)
Retention Period
6 Years Then Destroy
Imported from EPIC
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
20
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Download electronic document
View images
View plain text
Exhibit A (Scope of Work) <br /> <br />IV. Scope <br />A. Provide in-person and telehealth opioid use counseling. Patients will receive <br />same day telemedicine, or in person visits where they are, or will be transported <br />to an appointment for initial or follow-up appointments at Conquer Clinics, or <br />the Swedish Edmonds Bridge Clinic. <br />B. Patients will receive prescriptions for buprenorphine and medicines to treat <br />affiliated needs, including skin infections and chronic conditions. <br />C. Provide health education and harm reduction counseling via peer delivered <br />advice. <br />D. Make referrals to primary care and MOUD providers in Everett including at the <br />SeaMar, CHC, and WSU at Providence clinics. Ideal Option, Conquer Addiction, <br />Compass, Providence and numerous other providers can continue MOUD if <br />patients prefer. <br />E. Interface with existing and to-be-developed dispatch system linking the EMOTE <br />service to community support team of city social workers, police and fire <br />responders, as needed. <br />F. Each person providing services under this scope must maintain any professional <br />licensure necessary for those services. With respect to medical personnel, the <br />City may require insurance in addition to the insurance requirements elsewhere <br />in the Agreement. Medical services may not commence until Service Provider <br />has all required medical-related insurance (malpractice/E&O) in place. <br />G. To the extent applicable, the Service Provider will comply with HIPAA and all <br />medical privacy laws. <br />V. Timeline and Clinical Care <br />The EMOTE pilot is anticipated to last a minimum of two years. The first phase of the program <br />will consist of building programmatic infrastructure, including acquiring, outfitting and branding <br />a vehicle, hiring and training an SUD peer, and aligning insurance coverage with the goals of the <br />service. Once established, the EMOTE team would begin with 5 day a week service with 1-2 <br />days/week supported by an in-person provider (MD, PA-C, or ARNP) and the remainder of time <br />with service provided by a certified peer counselor. Field shifts would be 4-6 hours in duration <br />to account for setup and transportation. Peers would maintain an ongoing care panel of 10 <br />patients in addition to the daily outreach tasks. Data review by City staff may occur every 3 <br />months to provide ongoing process improvement. <br />VI. Evaluation of Impact <br />A comprehensive assessment of the impact of EMOTE will be undertaken quarterly, at a <br />minimum, to identify its impact on community provided opioid addiction care, to provide <br />ongoing process improvement, and to identify avenues for long term viability of the program. <br />We will contract with Collective Medical to use the Washington Emergency Department
The URL can be used to link to this page
Your browser does not support the video tag.